Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Clinical Psychopharmacology|June 15, 2022
Association Between CYP2D6 Metabolizer Status and Vortioxetine Exposure and Treatment Switching: A Retrospective, Naturalistic Cohort Study Using Therapeutic Drug Monitoring Data From 640 PatientsTrine Frederiksen, Robert L Smith, Marin M Jukic, et al.
Pharmacogenomics|July 25, 2018
Functional characterization of CYP2D7 gene variantsMarin M Jukic, Volker M Lauschke, Takahiro Saito, et al.
The Lancet. Psychiatry|April 20, 2019
Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort studyMarin M Jukic, Robert L Smith, Tore Haslemo, et al.
Clinical and Translational Science|June 7, 2022
Impact of the novel CYP2C:TG haplotype and CYP2B6 variants on sertraline exposure in a large patient populationLine Skute Bråten, Magnus Ingelman-Sundberg, Marin M Jukic, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 26, 2019
Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patientsLine S Bråten, Tore Haslemo, Marin M Jukic, et al.
JAMA Network Open|August 8, 2024
Pharmacogenetic Variants and Plasma Concentrations of Antiseizure Drugs: A Systematic Review and Meta-AnalysisFilip Milosavljevic, Marina Manojlovic, Lena Matkovic, et al.
Schizophrenia Research|November 22, 2020
Rates of complete nonadherence among atypical antipsychotic drugs: A study using blood samples from 13,217 outpatients with psychotic disordersRobert L Smith, Marit Tveito, Lennart Kyllesø, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 30, 2020
Impact of antipsychotic polypharmacy on nonadherence of oral antipsychotic drugs - A study based on blood sample analyses from 24,239 patientsRobert L Smith, Marit Tveito, Lennart Kyllesø, et al.
Clinical Pharmacology and Therapeutics|March 24, 2021
A Novel CYP2C-Haplotype Associated With Ultrarapid Metabolism of EscitalopramLine Skute Bråten, Tore Haslemo, Marin M Jukic, et al.
Plos One|October 8, 2015
Otx2 Requires Lmx1b to Control the Development of Mesodiencephalic Dopaminergic NeuronsOrna Sherf, Limor Nashelsky Zolotov, Keren Liser, et al.
Pageof 2